From the Journals

Location matters when it comes to thyroidectomy rates


 

FROM JAMA OTOLARYNGOLOGY–HEAD & NECK SURGERY

Thyroidectomy rates differ widely across the United States, according to a cross-sectional analysis of Medicare beneficiaries, but researchers aren’t sure what’s driving the variation.

There was a 6.2-fold difference in thyroidectomy rates across U.S. hospital referral regions in 2014, ranging from 22 to 139 per 100,000 Medicare beneficiaries. The national average was 60 procedures per 100,000 Medicare beneficiaries, David O. Francis, MD, of the University of Wisconsin, Madison, and his coauthors, reported (JAMA Otolaryngol Head Neck Surg. 2017 Oct 12. doi: 10.1001/jamaoto.2017.1746).

The researchers conducted a cross-sectional analysis of 15,888 Medicare beneficiaries aged 65 years and older who underwent a thyroidectomy in 2014. Of the thyroidectomies performed, 7,056 were partial and 8,382 were total thyroidectomies. They compared the frequency of partial and total thyroidectomies to total prostatectomy rates (high variation) and hospitalizations for hip fractures (low variation).

The stark variation in thyroidectomy outpaced those in hip fracture hospitalization (2.2-fold variation) and radical prostatectomy (5.6-fold variation) across U.S. hospital referral regions.

Higher rates of thyroidectomy were seen in Southern, Central, and certain urban regions of the United States.

But the variation in rates did not correlate with health care availability, socioeconomic status, or the availability of surgeons. This suggests that variation is caused by something other than disease burden. The researchers speculated that the “variability in thyroid surgery rates in areas with similar access to surgical services largely relates to local beliefs and practice patterns.”

The researchers also noted that the findings, which are based on Medicare data, may not be generalizable to young patients who account for more than half of all thyroidectomies performed in the United States.

The study was funded by the Department of Veterans Affairs and the Dartmouth Institute for Health Policy & Clinical Practice, with salary support from the National Institutes of Health. The researchers reported having no relevant conflicts of interest.

Recommended Reading

Biotin interference a concern in hormonal assays
MDedge Endocrinology
In hypoparathyroidism, phosphate, calcium levels may matter
MDedge Endocrinology
Symptoms fail to predict benefit of hormone therapy in older adults with subclinical hypothyroidism
MDedge Endocrinology
Papillary thyroid microcarcinoma: Is ‘less is more’ the right approach?
MDedge Endocrinology
Add-on mycophenolate boosts efficacy of steroids for Graves’ orbitopathy
MDedge Endocrinology
Long-term methimazole therapy improves Graves disease remission rate
MDedge Endocrinology
Patients prefer higher dose of levothyroxine despite lack of objective benefit
MDedge Endocrinology
Hypothyroidism carries higher surgical risk not captured by calculator
MDedge Endocrinology
Autoimmune endocrinopathies spike after celiac disease diagnosis
MDedge Endocrinology
Generic, brand-name levothyroxine have similar cardiovascular outcomes
MDedge Endocrinology